Brief: Scope Fluidics Subsidiary Gets To "Proof-Of-Concept" Stage For Panel Detecting SARS-CoV-2
15/05/2020 08:24
May 15 (Reuters) - Scope Fluidics SA SCPP.WA :
* SAYS CURIOSITY DIAGNOSTICS GETS TO STAGE OF
"PROOF-OF-CONCEPT"
IN DEVELOPMENT OF PANEL ALLOWING TO CONDUCT TEST ON SARS-COV-2
PRESENCE WITH USAGE OF PCR|ONE SYSTEM
Source text for Eikon: ID:nEM74jMmMa
Further company coverage: SCPP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics Extends Deadline For First Milestone Of Hybolic Project To End Of Q3 2026
Brief: Scope Fluidics Says Bacteromic Granted U.S. Patent 'Microfluidic Chip'
Brief: Scope Fluidics Q1 Net Loss At 13.5 Million Zlotys
Brief: Scope Fluidics Unit Bacteromic Starts Collaboration With US Research Center For FDA Registration Trials
Brief: Scope Fluidics FY Net Loss At 46.4 Million Zlotys